Abiopharma

News list

Lee-Sepsick Kathy 🟢 acquired 97.1K shares (1 derivative) of FEMASYS INC (FEMY) at $0.52 Transaction Date: Aug 27, 2025 | Filing ID: 033197

Full text

News bot Aug. 28, 2025, 8:34 p.m.
🔍 Lee-Sepsick Kathy (Executive)

Company: FEMASYS INC (FEMY)

Report Date: 2025-08-27
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 97,070
- Total shares held: 72,223
Detailed Transactions and Holdings:
- Acquired 48,535 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: I | equity_swap_involved: 0 | shares_owned_after: 360,627.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-08-27 | Code: H | nature_of_ownership: By the Lee-Sepsick Family Trust | shares_owned_after: 72,223.00
- Acquired 48,535 shares of Common Warrants (right to buy) at $0.5151 per share (Derivative)
  Date: 2025-08-27 | Code: I | Expires: 2030-08-27 | Exercise: 2025-08-27 | equity_swap_involved: 0 | shares_owned_after: 48,535.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The reported securities are included within 48,535 Units purchased by the reporting person for $0.5151 per Unit in an underwritten public offering pursuant to the Registration Statement on Form S-1 (File No. 333-289722). Each Unit consists of one share of common stock and one warrant to purchase one share of common stock.